Cyfuse Biomedical K.K. (TYO:4892)
Japan
· Delayed Price · Currency is JPY 644.00
+23.00 (3.70%)
Mar 10, 2026, 11:09 AM JST
Cyfuse Biomedical K.K. Market Cap
Cyfuse Biomedical K.K. has a market cap or net worth of 6.19 billion as of March 9, 2026. Its market cap has increased by 36.46% in one year.
Market Cap
6.19B
Enterprise Value
3.77B
Revenue
230.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
644.00
Market Cap Chart
Since December 1, 2022, Cyfuse Biomedical K.K.'s market cap has decreased from 13.00B to 6.19B, a decrease of -52.41%. That is a compound annual growth rate of -20.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 6.19B | 9.11% |
| Dec 30, 2025 | 5.67B | 54.23% |
| Dec 30, 2024 | 3.68B | -38.27% |
| Dec 29, 2023 | 5.96B | -37.68% |
| Dec 30, 2022 | 9.56B | -26.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedRx | 6.35B |
| Nippon Chemiphar | 6.41B |
| WDB coco | 6.50B |
| SymBio Pharmaceuticals | 7.74B |
| Modalis Therapeutics | 5.16B |
| Solasia Pharma K.K. | 9.15B |
| Morishita Jintan | 9.53B |
| Wakamoto Pharmaceutical | 11.83B |